Quick Takeaways
- Invesco Ltd. filed SCHEDULE 13G/A for ADMA Biologics Inc Common Stock (ADMA).
- Disclosed ownership: 4.8%.
- Date of event: 31 Dec 2024.
Invesco Ltd. - 31 Dec 2024 SCHEDULE 13G/A Report for ADMA Biologics Inc Common Stock (ADMA)
- Filing Manager
- Invesco Ltd.
- Reporting Manager
- Invesco Ltd.
- Security
- ADMA Biologics Inc Common Stock
- Symbol
- ADMA
- Shares outstanding
- 235,338,646 shares
- Disclosed Ownership
- 11,296,255 shares
- Ownership
- 4.8%
- Form type
- SCHEDULE 13G/A
- Filing time
- 07 Feb 2025, 13:51:28 UTC
- Date of event
- 31 Dec 2024
- Next filing
- 09 May 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Invesco Ltd. disclosed 4.8% ownership in ADMA Biologics Inc Common Stock (ADMA) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 07 Feb 2025, 13:51.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Invesco Ltd. | 4.8% | 11,296,255 | 10,692,790 | 0 | Robert R. Leveille | Global Head of Compliance |